Transferrin: a blood coagulation modifier

Alvin H. Schmaier

DOI: https://doi.org/10.1038/s41422-020-0275-z

IF: 44.1

2020-01-17

Cell Research

Abstract:Cell Research, Published online: 17 January 2020; doi:10.1038/s41422-020-0275-zTransferrin: a blood coagulation modifier

cell biology

What problem does this paper attempt to address?

Transferrin’ across the blood–brain barrier

Joseph Willson

DOI: https://doi.org/10.1038/d41573-020-00102-3

IF: 112.288

2020-06-05

Nature Reviews Drug Discovery

Abstract:<p>Nature Reviews Drug Discovery, Published online: 05 June 2020; <a href="https://www.nature.com/articles/d41573-020-00102-3">doi:10.1038/d41573-020-00102-3</a></p>Transferrin' across the blood–brain barrier

pharmacology & pharmacy,biotechnology & applied microbiology
Transferrin and its receptor: Their roles in cell function

Adrian B. Bomford,Hamish N. Munro

DOI: https://doi.org/10.1002/hep.1840050528

IF: 17.298

1985-09-01

Hepatology

Abstract:Transferrin, its receptor and the entry of iron into the cell have sprung into prominence because of recent evidence that proliferation of various cell types involves regulation of this sequence of events, as evidenced especially by changes in receptor number. A third component functionally linked to transferrin and its receptor is the intracellular iron-storage protein, ferritin, which ensures against toxic levels of free ferrous iron, which might otherwise cause peroxidative damage to cell membranes and other cell structures (1). In this article, we shall focus on interactions between these three proteins of iron exchange, their roles in homeostasis and especially their role in relation to the liver which is a major organ of iron storage.

gastroenterology & hepatology
Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity

M Boshuizen,K van der Ploeg,L von Bonsdorff,B J Biemond,S S Zeerleder,R van Bruggen,N P Juffermans

DOI: https://doi.org/10.1016/j.blre.2017.07.005

Abstract:As the main iron transporter, transferrin delivers iron to target tissues like the bone marrow for erythropoiesis. Also, by binding free iron, transferrin prevents formation of reactive oxygen species. Transferrin deficiency due to congenital hypotransferrinemia is characterized by anemia as well as oxidative stress related to toxic free iron. Transferrin supplementation may be beneficial in two ways. First, transferrin can correct anemia by modulating the amount of iron that is available for erythropoiesis. This is obvious for patients that suffer from hypotransferrinemia, but may also have beneficial effects for β-thalassemia patients. Second, under conditions of iron overload, transferrin reduces oxidative stress by binding free iron in the circulation and in tissues. Hereby, transferrin protects the host against the reactive oxygen species that can be formed as a consequence of free iron. This beneficial effect is shown in hematological patients undergoing chemotherapy and stem cell transplantation. Transferrin may also be beneficial in lung injury, ischemia-reperfusion injury and hypomyelination. This review summarizes the preclinical and clinical data on the efficacy of exogenous transferrin administration to modulate certain forms of anemia and to prevent the toxic effects of free iron. Thereby, we show that transferrin has promising therapeutic potential in a wide variety of conditions.
Known and potential roles of transferrin in iron biology

Thomas Benedict Bartnikas

DOI: https://doi.org/10.1007/s10534-012-9520-3

2012-02-01

BioMetals

Abstract:Transferrin is an abundant serum metal-binding protein best known for its role in iron delivery. The human disease congenital atransferrinemia and animal models of this disease highlight the essential role of transferrin in erythropoiesis and iron metabolism. Patients and mice deficient in transferrin exhibit anemia and a paradoxical iron overload attributed to deficiency in hepcidin, a peptide hormone synthesized largely by the liver that inhibits dietary iron absorption and macrophage iron efflux. Studies of inherited human disease and model organisms indicate that transferrin is an essential regulator of hepcidin expression. In this paper, we review current literature on transferrin deficiency and present our recent findings, including potential overlaps between transferrin, iron and manganese in the regulation of hepcidin expression.

biochemistry & molecular biology
Structure, Function and Clinical Significance of Transferrin Receptors

Richard A. Feelders,Ellen P. A. Kuiper-Kramer,Henk G. van Eijk

DOI: https://doi.org/10.1515/cclm.1999.001

1999-01-01

cclm

Abstract:Abstract Iron plays an essential role in a spectrum of metabolic processes. Cellular iron uptake is facilitated by transferrin receptor (TfR)-mediated endocytosis. In recent years more insight has been obtained in TfR physiology and the regulation of cellular iron homeostasis. The synthesis of TfR and the iron storage protein ferritin is regulated reciprocally at the post-transcriptional level according to the cellular iron status. As a result of externalization of TfR during the endocytic cycle, a soluble form of TfR can be detected in serum. The serum TfR (sTfR) level is closely related to erythroid TfR turnover and the prime determinants of the sTfR concentration are cellular iron demands and erythroid proliferation rate. In the absence of a hyperplastic erythropoiesis the sTfR level is a sensitive parameter of early tissue iron deficiency. The entire spectrum of body iron status can be assessed by measurement of serum ferritin and sTfR levels, with ferritin as marker of tissue iron stores and sTfR as index of tissue iron needs. The sTfR may be a promising tool to detect iron deficiency in inflammatory states and in the anaemia of chronic disease as its concentration is, in contrast to ferritin levels, not influenced by the acute phase response. Determination of sTfR levels may also improve assessment of body iron stores during pregnancy and in neonates. Finally, the sTfR may be a useful parameter to monitor erythropoiesis in various clinical settings, for instance in the prediction of the haematological response to erythropoietin treatment. However, standardization of the sTfR assay, with definition of reference and pathological ranges, is necessary for the definitive introduction of the sTfR as major parameter of iron metabolism.
Transferrin and transferrin receptors update

Hiroshi Kawabata

DOI: https://doi.org/10.1016/j.freeradbiomed.2018.06.037

IF: 8.101

2019-03-01

Free Radical Biology and Medicine

Abstract:In vertebrates, transferrin (Tf) safely delivers iron through circulation to cells. Tf-bound iron is incorporated through Tf receptor (TfR) 1-mediated endocytosis. TfR1 can mediate cellular uptake of both Tf and H-ferritin, an iron storage protein. New World arenaviruses, which cause hemorrhagic fever, and Plasmodium vivax use TfR1 for entry into host cells. Human TfR2, another receptor for Tf, is predominantly expressed in hepatocytes and erythroid precursors, and holo-Tf dramatically upregulates its expression. TfR2 forms a complex with hemochromatosis protein, HFE, and serves as a component of the iron sensing machinery in hepatocytes. Defects in TfR2 cause systemic iron overload, hemochromatosis, through down-regulation of hepcidin. In erythroid cells, TfR2 forms a complex with the erythropoietin receptor and regulates erythropoiesis. TfR2 facilitates iron transport from lysosomes to mitochondria in erythroblasts and dopaminergic neurons. Administration of apo-Tf, which scavenges free iron, has been explored for various clinical conditions including atransferrinemia, iron overload, and tissue ischemia. Apo-Tf has also been shown to ameliorate anemia in animal models of β-thalassemia. In this review, I provide an update and summary on our knowledge of mammalian Tf and its receptors.

biochemistry & molecular biology,endocrinology & metabolism
The Transferrin Receptor: Its Diagnostic Value and its Potential as Therapeutic Target

Ketil Thorstensen,Inge Romslo

DOI: https://doi.org/10.3109/00365519309090703

1993-01-01

Scandinavian Journal of Clinical and Laboratory Investigation

Abstract:Transferrin receptors are present on almost all mammalian cells. The receptor participates in the cellular acquisition of iron from transferrin by receptor-mediated endocytosis. Receptor abundancy is generally regulated by two factors: i) cellular iron status and ii) cell growth. These two factors form the basis for the utilization of transferrin receptor determination as a diagnostic tool. In the assessment of body iron status and erythropoietic activity the measurement of circulating transferrin receptor has proved to be of value as a measure of mild tissue iron deficiency, to distinguish iron deficiency anemia from the anemias of chronic disease, and as a sensitive index of iron deficiency during pregnancy. Histochemical analysis of the presence and abundancy of the transferrin receptor will continue to serve as an additional tool in special cases to distinguish between malignant and normal cell growth, and to provide additional information about the biological behaviour of tumor cells. Finally, the transferrin receptor holds a potential as a target for direct and indirect drug delivery in the therapy of malignant cell growth.

medicine, research & experimental
New regulators of systemic iron homeostasis

Tomas Ganz

DOI: https://doi.org/10.1038/s41392-021-00696-z

IF: 39.3

2021-07-21

Signal Transduction and Targeted Therapy

Abstract:Signal Transduction and Targeted Therapy, Published online: 21 July 2021; doi:10.1038/s41392-021-00696-zNew regulators of systemic iron homeostasis

biochemistry & molecular biology,cell biology
Monoclonal Antibodies to Transferrin Receptors

Ian S. Trowbridge,Roland A. Newman

DOI: https://doi.org/10.1007/978-94-009-5566-0_10

1984-01-01

Abstract:Iron plays an important role in cell growth and metabolism, and as many key reactions in energy metabolism and DNA synthesis are catalyzed by iron-containing enzymes, some biologists have considered it likely that iron was an obligatory requirement during the earliest phases of the evolution of life (Shapira, 1964; Neilands, 1972). Under most physiological conditions, however, the iron atom exists in its oxidized ferric (Fe3+) state and at neutral pH ferric salts are hydrolyzed to insoluble ferric hydroxide. Thus ferric ions in excess of 2.5 × 10–18 M are insoluble. To combat this problem, organisms have developed various systems to maintain iron in a soluble form and transport it into the cell. Micro-organisms have solved this problem by producing and secreting various soluble iron-chelating molecules referred to as siderophores (Neilands, 1981) whereas vertebrates have developed a family of closely related iron-binding proteins collectively known as the transferrins (Aisen and Listowsky, 1980).
Excess of circulating apo-transferrin enhances dietary iron absorption

Sofiya Tsyplenkova,Edouard Charlebois,Carine Fillebeen,Kostas Pantopoulos

DOI: https://doi.org/10.1182/blood.2023022916

IF: 20.3

2024-03-27

Blood

Abstract:Intravenous injection of excess apo-transferrin enhances dietary iron absorption in mice, and triggers accumulation of plasma non-transferrin bound iron (NTBI). Injected fluorescent-labeled transferrin colocalizes with lamina propria macrophages, consistent with the recently proposed iron absorption checkpoint involving macrophage-mediated transferrin degradation.

hematology
[Recent Research Progresses of Transferrin Receptor 1 in Central Nervous System].

Qiong Li,Liang Zhou,Ying Shen

DOI: https://doi.org/10.3969/j.issn.0559-7765.2012.03.006

2012-01-01

Abstract:Transferrin receptor 1 exists widely in central nervous system (CNS). It is responsible for iron transport in vivo and mediates the endocytosis of transferring-iron complex, regulating the cell growth. TfR1 transports other metal ions as well, such as Mn, Al and Cu. It is proved that TfR1 can help macromolecular drugs to pass through the blood-brain barrier and emerges as a potential therapeutic target of neurological diseases in CNS. This review summarizes recent findings in distribution, function, and modulatory mechanisms of TfR1 as well as its applications as therapeutic targets in clinical medicine. The investigations on these issues can not only provide new ideas for the research about the mechanism and function of TfR1, but also have profound significance in the understanding of neuroscience.
Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia

Yihang Li,Ian Miller,Princy Prasad,Nisha Ajit George,Nermi L. Parrow,Robert E. Fleming

DOI: https://doi.org/10.3389/fphys.2022.893149

IF: 4

2022-05-12

Frontiers in Physiology

Abstract:Erythropoietic response is controlled not only by erythropoietin but also by iron. In addition to its role in iron delivery, transferrin also functions as a signaling molecule, with effects on both iron homeostasis and erythropoiesis. We investigated hematologic parameters, iron status and expression of key proteins, including the hepatic iron regulatory protein hepcidin and the suppressive erythroid factor Erfe , in mice subject to dietary iron deficiency with and without anemia. The acute effect of iron on these parameters was investigated by administration of exogenous iron-loaded transferrin (holoTf) in each of the mouse models. Serum iron in mice with iron deficiency (ID) is modestly lower with hematologic parameters maintained by utilization of iron stores in mice with ID. As expected, erythropoietin expression and concentration, along with marrow Erfe are unaffected in ID mice. Administration of holoTf restores serum iron and Tf saturation levels to those observed in control mice and results in an increase in hepcidin compared to ID mice not treated with holoTf. The expression of the Bmp signaling molecule Bmp6 is not significantly increased following Tf treatment in ID mice. Thus, the expression level of the gene encoding hepcidin, Hamp1 , is increased relative to Bmp6 expression in ID mice following treatment with holoTf, leading us to speculate that Tf saturation may influence Bmp sensitivity. In mice with iron deficiency anemia (IDA), decreased hematologic parameters were accompanied by pronounced decreases in serum and tissue iron concentrations, and an increase in serum erythropoietin. In the absence of exogenous holoTf, the greater serum erythropoietin was not reflected by an increase in marrow Erfe expression. HoloTf administration did not acutely change serum Epo in IDA mice. Marrow Erfe expression was, however, markedly increased in IDA mice following holoTf, plausibly accounting for the lack of an increase in Hamp1 following holoTf treatment in the IDA mice. The increase in Erfe despite no change in erythropoietin suggests that Tf acts to increase erythropoietin sensitivity. These observations underscore the importance of Tf in modulating the erythropoietic response in recovery from iron deficiency anemia, with implications for other stress erythropoiesis conditions.

physiology
Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis

Giovanni Cimmino,Plinio Cirillo

DOI: https://doi.org/10.21037/cdt.2018.10.14

Abstract:For many years, the attention on tissue factor (TF) in human pathophysiology has been limited to its role as initiator of extrinsic coagulation pathway. Moreover, it was described as a glycoprotein located in several tissue including vascular wall and atherosclerotic plaque. However, in the last two decades, the discovery that TF circulates in the blood as cell-associated protein, microparticles (MPs) bound and as soluble form, is changing this old vessel-wall TF dogma. Moreover, it has been reported that TF is expressed by different cell types, even T lymphocytes and platelets, and different pathological conditions, such as acute and chronic inflammatory status, and cancer, may enhance its expression and activity. Thus, recent advances in the biology of TF have clearly indicated that beyond its known effects on blood coagulation, it is a "true surface receptor" involved in many intracellular signaling, cell-survival, gene and protein expression, proliferation, angiogenesis and tumor metastasis. Finally, therapeutic modulation of TF expression and/or activity has been tested with controversial results. This report, starting from the old point of view about TF as initiator of extrinsic coagulation pathway, briefly illustrates the more recent concepts about TF and thrombosis and finally gives an overview about its role beyond thrombosis and haemostasis focusing on the different intracellular mechanisms triggered by its activation and potentially involved in atherosclerosis.
The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells

Carly E. Herbison,Ketil Thorstensen,Anita C. G. Chua,Ross M. Graham,Peter Leedman,John K. Olynyk,Debbie Trinder

DOI: https://doi.org/10.1152/ajpcell.00649.2008

2009-12-01

Abstract:Transferrin receptor (TFR) 1 and 2 are expressed in the liver; TFR1 levels are regulated by cellular iron levels while TFR2 levels are regulated by transferrin saturation. The aims of this study were to 1) determine the relative importance of TFR1 and TFR2 in transferrin-bound iron (TBI) uptake by HuH7 human hepatoma cells and 2) characterize the role of metal-transferrin complexes in the regulation of these receptors. TFR expression was altered by 1) incubation with metal-transferrin (Tf) complexes, 2) TFR1 and TFR2 small interfering RNA knockdown, and 3) transfection with a human TFR2 plasmid. TBI uptake was measured using 59 Fe- 125 I-labeled Tf and mRNA and protein expression by real-time PCR and Western blot analysis, respectively. Fe 2 Tf, Co 2 Tf, and Mn 2 Tf increased TFR2 protein expression, indicating that the upregulation was not specifically regulated by iron-transferrin but also other metal-transferrins. In addition, Co 2 Tf and Mn 2 Tf upregulated TFR1, reduced ferritin, and increased hypoxia-inducible factor-1α protein expression, suggesting that TFR1 upregulation was due to a combination of iron deficiency and chemical hypoxia. TBI uptake correlated with changes in TFR1 but not TFR2 expression. TFR1 knockdown reduced iron uptake by 80% while TFR2 knockdown did not affect uptake. At 5 μM transferrin, iron uptake was not affected by combined TFR1 and TFR2 knockdown. Transfection with a hTFR2 plasmid increased TFR2 protein expression, causing a 15–20% increase in iron uptake and ferritin levels. This shows for the first time that TFR-mediated TBI uptake is mediated primarily via TFR1 but not TFR2 and that a high-capacity TFR-independent pathway exists in hepatoma cells.
Transferrin and Transferrin Receptor Function in Brain Barrier Systems

Torben Moos,Evan H. Morgan

DOI: https://doi.org/10.1023/a:1006948027674

2000-01-01

Cellular and Molecular Neurobiology

Abstract:Abstract1. Iron (Fe) is an essential component of virtually all types of cells and organisms. In plasma and interstitial fluids, Fe is carried by transferrin. Iron-containing transferrin has a high affinity for the transferrin receptor, which is present on all cells with a requirement for Fe. The degree of expression of transferrin receptors on most types of cells is determined by the level of Fe supply and their rate of proliferation.2. The brain, like other organs, requires Fe for metabolic processes and suffers from disturbed function when a Fe deficiency or excess occurs. Hence, the transport of Fe across brain barrier systems must be regulated. The interaction between transferrin and transferrin receptor appears to serve this function in the blood–brain, blood–CSF, and cellular–plasmalemma barriers. Transferrin is present in blood plasma and brain extracellular fluids, and the transferrin receptor is present on brain capillary endothelial cells, choroid plexus epithelial cells, neurons, and probably also glial cells.3. The rate of Fe transport from plasma to brain is developmentally regulated, peaking in the first few weeks of postnatal life in the rat, after which it decreases rapidly to low values. Two mechanisms for Fe transport across the blood–brain barrier have been proposed. One is that the Fe–transferrin complex is transported intact across the capillary wall by receptor-mediated transcytosis. In the second, Fe transport is the result of receptor-mediated endocytosis of Fe–transferrin by capillary endothelial cells, followed by release of Fe from transferrin within the cell, recycling of transferrin to the blood, and transport of Fe into the brain. Current evidence indicates that although some transcytosis of transferrin does occur, the amount is quantitatively insufficient to account for the rate of Fe transport, and the majority of Fe transport probably occurs by the second of the above mechanisms.4. An additional route of Fe and transferrin transport from the blood to the brain is via the blood–CSF barrier and from the CSF into the brain. Iron-containing transferrin is transported through the blood–CSF barrier by a mechanism that appears to be regulated by developmental stage and iron status. The transfer of transferrin from blood to CSF is higher than that of albumin, which may be due to the presence of transferrin receptors on choroid plexus epithelial cells so that transferrin can be transported across the cells by a receptor-mediated process as well as by nonselective mechanisms.5. Transferrin receptors have been detected in neurons in vivo and in cultured glial cells. Transferrin is present in the brain interstitial fluid, and it is generally assumed that Fe which transverses the blood–brain barrier is rapidly bound by brain transferrin and can then be taken up by receptor-mediated endocytosis in brain cells. The uptake of transferrin-bound Fe by neurons and glial cells is probably regulated by the number of transferrin receptors present on cells, which changes during development and in conditions with an altered iron status.6. This review focuses on the information available on the functions of transferrin and transferrin receptor with respect to Fe transport across the blood–brain and blood–CSF barriers and the cell membranes of neurons and glial cells.

neurosciences,cell biology
Research advance on transfusion-related immunomodulation]

Xin-Fang Zhu,Rong Xia

2010-01-01

Abstract:As allogeneic blood transfusion plays a role in clinical treatment effects, it also produces a number of immune-related side effects, such as the increased rate of postoperative infection, the rising relapse rate of malignant resection and so on. All those factors, such as CD200 surface molecule of allogeneic mononuclear cells, interleukin, sHLA and sFasL which are detached from the leukocyte surface during the period of storage, and serum bioactive molecules related to a certain degree with the occurrence of transfusion-related immunomodulation (TRIM). The clinical controlled trials, laboratory researches and animal models demonstrated that cloning deletion, induction of anergy and immune suppression are the three major mechanisms of TRIM. In this article, the research advances on mechanism of TRIM and the mediators inducing TRIM are reviewed.
Hemostasis and endothelial functionality: the double face of coagulation factors

Cristina Olgasi,Simone Assanelli,Alessia Cucci,Antonia Follenzi

DOI: https://doi.org/10.3324/haematol.2022.282272

2024-03-02

Haematologica

Abstract:Hemostasis is a sophisticated sequence of events aimed to repair vessel injury. This process occurs in combination with angiogenesis, which leads to new blood vessel formation helping in the wound repair and facilitating tissue healing. The fine mechanisms that regulate hemostasis and angiogenesis are well described, but for long time, coagulation factors (CFs) have been considered merely players in the coagulation cascade. However, several experimental evidences highlight the crucial functions of these CFs in regulating endothelial functionality, especially in the angiogenic process. Some of these CFs (e.g. thrombin and tissue factor) have been widely investigated and have been described to trigger intracellular signaling related to endothelial cell (EC) functionality. For others (e.g. factor VIII and thrombomodulin), potential receptors and molecular mechanisms have not been fully elucidated but some data show their potential to induce EC response. This review focuses on the emerging roles of selected CFs in regulating EC functions, especially highlighting their ability to activate signaling pathways involved in the angiogenesis, migration, proliferation and endothelial barrier stability.

hematology
Chemistry and biology of ferritin

Marina Plays,Sebastian Müller,Raphaël Rodriguez

DOI: https://doi.org/10.1093/mtomcs/mfab021

2021-04-21

Metallomics

Abstract:Abstract Iron is an essential element required by cells and has been described as a key player in ferroptosis. Ferritin operates as a fundamental iron storage protein in cells forming multimeric assemblies with crystalline iron cores. We discuss the latest findings on ferritin structure and activity and its link to cell metabolism and ferroptosis. The chemistry of iron, including its oxidation states, is important for its biological functions, its reactivity, and the biology of ferritin. Ferritin can be localized in different cellular compartments and secreted by cells with a variety of functions depending on its spatial context. Here, we discuss how cellular ferritin localization is tightly linked to its function in a tissue-specific manner, and how impairment of iron homeostasis is implicated in diseases, including cancer and coronavirus disease 2019. Ferritin is a potential biomarker and we discuss latest research where it has been employed for imaging purposes and drug delivery.

biochemistry & molecular biology
Blood transfusion, alcohol abuse and altruism

Shaun R. McCann

DOI: https://doi.org/10.1038/s41409-024-02325-z

2024-06-06

Bone Marrow Transplantation

Abstract:Bone Marrow Transplantation, Published online: 05 June 2024; doi:10.1038/s41409-024-02325-z Blood transfusion, alcohol abuse and altruism

oncology,immunology,hematology,transplantation

Transferrin: a blood coagulation modifier

Transferrin’ across the blood–brain barrier

Transferrin and its receptor: Their roles in cell function

Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity

Known and potential roles of transferrin in iron biology

Structure, Function and Clinical Significance of Transferrin Receptors

Transferrin and transferrin receptors update

The Transferrin Receptor: Its Diagnostic Value and its Potential as Therapeutic Target

New regulators of systemic iron homeostasis

Monoclonal Antibodies to Transferrin Receptors

Excess of circulating apo-transferrin enhances dietary iron absorption

[Recent Research Progresses of Transferrin Receptor 1 in Central Nervous System].

Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia

Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis

The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells

Transferrin and Transferrin Receptor Function in Brain Barrier Systems

Research advance on transfusion-related immunomodulation]

Hemostasis and endothelial functionality: the double face of coagulation factors

Chemistry and biology of ferritin

Blood transfusion, alcohol abuse and altruism